Science Explorer Back to mapMap
Discussion
Hospital / health system · Norfolk · United States

Digestive & Liver Disease Specialists

glstva.com/norfolk/#.Wk2ymdKWbIUROR OpenAlex
Research works
23
▲ 302% vs 2018-21
Citations
243
10.5 per fractional work
Top-10% rate
11.0%
all institutions 10.0%
Open access
8%
world 40%
International
11%
world 18%
Digestive & Liver Disease Specialists

Not ranked overall: Digestive & Liver Disease Specialists is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Digestive & Liver Disease Specialists work in?

In all years, 93% of research at Digestive & Liver Disease Specialists is in Health Sciences, 6% in Life Sciences. Its largest fields are Medicine (90%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (2%). It does 2.9× the world's share of Health Sciences.

Health Sciences: 21 fractional works · 92.7% of its workMedicine: 21 fractional works · 90.4% of its workSurgery: 9 fractional works · 37.4% of its workGastroenterology: 3 fractional works · 13.3% of its workPulmonary and Respiratory Medicine: 3 fractional works · 11.0% of its workEpidemiology: 1 fractional works · 5.6% of its workHepatology: 1 fractional works · 4.5% of its workInfectious Diseases: 1 fractional works · 3.0% of its workOncology: 1 fractional works · 2.9% of its workEmergency Medicine: 0 fractional works · 2.1% of its workPhysiology: 0 fractional works · 2.0% of its workPathology and Forensic Medicine: 0 fractional works · 1.4% of its workPharmacology: 0 fractional works · 1.1% of its workRheumatology: 0 fractional works · 1.0% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.0% of its workOtorhinolaryngology: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.5% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.5% of its workGeneral Health Professions: 0 fractional works · 1.3% of its workPharmacy: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.7% of its workNutrition and Dietetics: 0 fractional works · 0.7% of its workLife Sciences: 1 fractional works · 6.2% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 3.6% of its workMolecular Biology: 0 fractional works · 2.0% of its workGenetics: 0 fractional works · 0.9% of its workClinical Biochemistry: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 2.0% of its workImmunology: 0 fractional works · 1.5% of its workParasitology: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.9% of its workSocial Sciences: 0 fractional works · 0.7% of its workCultural Studies: 0 fractional works · 0.7% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workPhysical Sciences: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.2% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workALL ITS WORKDigestive & LiverDisease…23fractional works, all years
Life Sciences6%Physical Sciences0%Health Sciences93%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine2190.4%
    2. Health Professions01.5%
    3. Nursing00.7%
    1. Biochemistry, Genetics and Molecular Biology13.6%
    2. Immunology and Microbiology02.0%
    3. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Social Sciences00.7%
    2. Economics, Econometrics and Finance00.2%
    1. Chemistry00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Digestive & Liver Disease Specialists?

The most cited paper from Digestive & Liver Disease Specialists is "Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis" (Kris V. Kowdley et al., 2014), with 1,131 citations. Next come "A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis" (338) and "Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial" (331).

Most cited papers
#PaperReleasedCitations
1 Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis Kris V. Kowdley et al. · New England Journal of Medicine Open access 11 Apr 2014 1,131
2 A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis Nicholas C. Boetticher, Craig J. Peine, Paul Yien Kwo et al. · Gastroenterology Open access 14 Sep 2008 338
3 Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial Eric Lawitz et al. · The Lancet Infectious Diseases 15 Mar 2013 331
4 Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study David E. Jones et al. · ˜The œLancet. Gastroenterology & hepatology 15 Aug 2017 191
5 Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial Stanislas Pol et al. · The Lancet Infectious Diseases 18 Jun 2012 149
All 52 most cited papers, with filters and sorting

Which keywords describe research at Digestive & Liver Disease Specialists?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Treatment, Diagnosis, Complications, Children, Adults, Esophageal Motility Disorders and Gastroesophageal Reflux Disease.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Epidemiology9▲ 10.0×20 topics
  2. Treatment4▲ 14×8 topics
  3. Complications4▲ 30×3 topics
  4. Diagnosis4▲ 15×8 topics
  5. Children3▲ 48×3 topics
  6. Adults2▲ 148×2 topics
  7. Esophageal Motility Disorders2▲ 303×1 topic
  8. Gastroesophageal Reflux Disease2▲ 303×1 topic
  9. Gastric Cancer2▲ 84×3 topics
  10. Guidelines2▲ 22×4 topics
  11. Management2▲ 13×5 topics
  12. Inflammation2▲ 4.1×15 topics
  13. Eosinophilic Esophagitis2▲ 269×1 topic
  14. Histologic Remission2▲ 269×1 topic
  15. Antibiotic Resistance2▲ 17×2 topics
  16. Pathogenesis2▲ 12×4 topics
  17. Chemotherapy1▲ 8.3×8 topics
  18. Prevention1▲ 16×2 topics
  19. Survival Analysis1▲ 22×3 topics
  20. Palliative Treatment1▲ 80×2 topics
  21. Surgical Management1▲ 13×5 topics
  22. Endoscopic Stenting1▲ 103×1 topic
  23. Eradication Therapy1▲ 107×1 topic
  24. Esophageal Perforation1▲ 103×1 topic
  25. Helicobacter pylori1▲ 107×1 topic

Which research topics does Digestive & Liver Disease Specialists publish most on?

By volume in 2022-now: Esophageal and GI Pathology, Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment and Eosinophilic Esophagitis.

Esophageal and GI Pathol…1Esophageal and GI Pathology: 1 fractional worksGastric Cancer Managemen…0Gastric Cancer Management and Outcomes: 0 fractional worksGastrointestinal Tumor R…0Gastrointestinal Tumor Research and Treatment: 0 fractional worksEosinophilic Esophagitis0Eosinophilic Esophagitis: 0 fractional worksGastrointestinal disorders and treatments: 0 fractional worksBiliary and Gastrointestinal Fistulas: 0 fractional worksPancreatitis Pathology a…0Pancreatitis Pathology and Treatment: 0 fractional worksIntraperitoneal and Appendiceal Malignancies: 0 fractional worksMetastasis and carcinoma case studies: 0 fractional worksEsophageal Cancer Resear…0Esophageal Cancer Research and Treatment: 0 fractional works
SurgeryPulmonary and Respiratory MedicineGastroenterology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Esophageal and GI Pathology Surgery 1 works
  2. 2 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  3. 3 Gastrointestinal Tumor Research and Treatment Gastroenterology 0 works
  4. 4 Eosinophilic Esophagitis Surgery 0 works
  5. 5 Gastrointestinal disorders and treatments Surgery 0 works
  6. 6 Biliary and Gastrointestinal Fistulas Pulmonary and Respiratory Medicine 0 works
  7. 7 Pancreatitis Pathology and Treatment Surgery 0 works
  8. 8 Intraperitoneal and Appendiceal Malignancies Surgery 0 works
  9. 9 Metastasis and carcinoma case studies Pulmonary and Respiratory Medicine 0 works
  10. 10 Esophageal Cancer Research and Treatment Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available7.8%not open92.2%

World: 40% of research is openly available.

with international co-authors11.4%domestic only88.6%

World: 18% is written across borders.

How has Digestive & Liver Disease Specialists's research output changed?

Output in 2022-2025 was 302% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Digestive & Liver Disease Specialists as a percentage of every work published that year, 0.000090% in 2024.

still counting0.000050%0.00010%0.00015%Digestive & Liver Disease Specialists0.0000022% in 2025200020102020

Fractional works of Digestive & Liver Disease Specialists over all fractional works that year. How the balance of science has shifted.

Other research institutions in Norfolk

All research institutions in Norfolk

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Digestive & Liver Disease Specialists. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.